HIV-1 Capsid Inhibitors as Antiretroviral Agents

about

Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.Novel Therapeutic Approach for Inhibition of HIV-1 Using Cell-Penetrating Peptide and Bacterial Toxins.Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.

P2860

Q27324193-EA849F67-C202-4761-9253-3E4F3C662FC4 Q47144668-C0EF9E1E-9E22-4C3B-BCC3-CBE25E036F8B Q53720583-0DD8ECD2-8FDD-4D41-A75D-CD922AC32BFC

P2860

HIV-1 Capsid Inhibitors as Antiretroviral Agents

Item

http://www.wikidata.org/entity/Q36672006

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@ast

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@en

type

Item

label

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@ast

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@en

prefLabel

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@ast

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@en

P1476

HIV-1 Capsid Inhibitors as Antiretroviral Agents

@en

P2093

Susana T Valente

http://www.w3.org/2001/XMLSchema#string

Suzie Thenin-Houssier

http://www.w3.org/2001/XMLSchema#string

P2860

The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles

Identification of host proteins required for HIV infection through a functional genomic screen

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

MX2 is an interferon-induced inhibitor of HIV-1 infection

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor

A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat

Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection

The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid

Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution

Structure of the Antiviral Assembly Inhibitor CAP-1 Complex with the HIV-1 CA Protein

P304

270-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570162X14999160224103555

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26957201

http://www.w3.org/2001/XMLSchema#string

P932

4785820

http://www.w3.org/2001/XMLSchema#string

HIV-1 Capsid Inhibitors as Antiretroviral Agents

about

P2860

P2860

HIV-1 Capsid Inhibitors as Antiretroviral Agents

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932